USA flag logo/image

An Official Website of the United States Government

ARTIFICIAL KIDNEY MEMBRANES OF IMPROVED BIOCOMPATIBILITY

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
4898
Program Year/Program:
1988 / SBIR
Agency Tracking Number:
4898
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
University Medical Associates
530 S Jackson Street Louisville, KY 40202
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 1988
Title: ARTIFICIAL KIDNEY MEMBRANES OF IMPROVED BIOCOMPATIBILITY
Agency: HHS
Contract: N/A
Award Amount: $283,000.00
 

Abstract:

HEMODIALYSIS IS WIDELY USED TO SUSTAIN LIFE IN INDIVIDUALS WHO HAVE LOST KIDNEY FUNCTION. THE MEMBRANE MATERIAL MOST COMMONLY USED FOR THIS PURPOSE IS REGENERATED CELLULOSE. HOWEVER, REGENERATED CELLULOSE IS NOT INERT; IT STIMULATES THE COAGULATION AND COMPLEMENT SYSTEMS AND MAY BE A CAUSE OFBOTH ACUTE AND CHRONIC MORBIDITY FOR THE PATIENT. FURTHER, ITS PHYSICAL PROPERTIES LIMIT METHODS OF STERILIZATION AND ITS USEFULNESS FOR MULTIPLE USE. A SUBSTITUTE FOR REGENERA-TED CELLULOSE IS BEING SOUGHT BY DEVICE MANUFACTURERS. THE OBJECTIVE OF THIS PROGRAM IS TO DEVELOP ALTERNATIVES TO REGENERATED CELLULOSE. A VARIETY OF POLYMERS WILL BE FORMULATED THAT SHOULD POSSESS SUPERIOR BIOCOMPATIBILITY TO REGENERATED CELLULOSE, THAT HAVE PHYSICAL PROPERTIES SUITED TO REUSE AND ALTERNATIVE METHODS OF STERILIZATION, AND THAT CAN BE FABRICATED INTO MEMBRANES BY ECONOMICALLY VIABLE METHODS. THE MEMBRANES WILL BE TESTED IN VITRO TO (1) COMPARE THEIR BIOCOMPATIBILITY TO REGENERATED CELLULOSE, (2)EXAMINE THEIR THROMBOGENIC POTENTIAL, (3) EVALUATE THEIR PROPENSITY TO ACTIVATE COMPLEMENT, AND (4) ASSESS THEIR DIRECT ACTION, IF ANY, ON THE CELLULAR COMPONENTS OF BLOOD. UNIVERSITY MEDICAL ASSOCIATES WILL ENSURE THE MATERIALS ARE RESISTANT TO THE CHEMICALS USED FOR DIALYZER REUSE AND THAT THEY CAN BE FABRICATED INTO MEMBRANES WITH MASS TRANSFER PROPERTIES SUITABLE FOR HEMODIALYSIS. IN PHASE II OF THE PROGRAM, THE MOST PROMISING MATERIALS WILL BE FABRICATED INTO DIALYZERS AND THE RESULTS CONFIRMED IN VIVO USING AN ANIMAL MODEL. THIS WILL LEAD TO THE DEVELOPMENT AND CLINICAL TRIALS OF CLINICAL DIALYZERS.

Principal Investigator:

Richard A Ward
Principal Investigator
5025885241

Business Contact:

Small Business Information at Submission:

University Medical Associates
530 South Jackson Street Louisville, KY 40202

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No